APA (7th ed.) Citation

Mikol, D. D., DePaul, M., Lawrence, B., Toews, J., Collett, N., & Lukashev, M. (2022). A Placebo‐Controlled Phase I Study in Healthy Subjects Assessing NVG‐291, which Targets CNS Receptor Protein Tyrosine Phosphatase Sigma (PTPσ). Alzheimer's & dementia, 18(S10), -n/a. https://doi.org/10.1002/alz.059663

Chicago Style (17th ed.) Citation

Mikol, Daniel D., Marc DePaul, Betty Lawrence, Judy Toews, Nana Collett, and Matvey Lukashev. "A Placebo‐Controlled Phase I Study in Healthy Subjects Assessing NVG‐291, Which Targets CNS Receptor Protein Tyrosine Phosphatase Sigma (PTPσ)." Alzheimer's & Dementia 18, no. S10 (2022): -n/a. https://doi.org/10.1002/alz.059663.

MLA (9th ed.) Citation

Mikol, Daniel D., et al. "A Placebo‐Controlled Phase I Study in Healthy Subjects Assessing NVG‐291, Which Targets CNS Receptor Protein Tyrosine Phosphatase Sigma (PTPσ)." Alzheimer's & Dementia, vol. 18, no. S10, 2022, pp. -n/a, https://doi.org/10.1002/alz.059663.